Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Noncompaction Cardiomyopathy > Genetics and Family Screening > Flashcards

Genetics and Family Screening Flashcards

(59 cards)

Start Studying
1
Q

What is Noncompaction Cardiomyopathy (NCCM)?

A

NCCM is characterized by endocardial hypertrabeculation of the myocardium of the left ventricle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What genetic mutation was first identified as a cause of NCCM?

A

A mutation in the X-linked TAZ gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In what year was the first genetic cause for NCCM identified?

A

1997.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prevalence of mutations in sarcomere genes among NCCM patients?

A

Sarcomere genes are the most prevalent genetic causes of NCCM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percentage of NCCM patients have a mutation identified through next generation sequencing?

A

Around 35%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What proportion of NCCM patients are considered to have a genetic cause?

A

Approximately 50%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the recommendation for relatives of patients diagnosed with NCCM?

A

Referral for genetic counseling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or False: In 45% of familial NCCM, no mutation can be identified.

A

True.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What types of genetic causes are recognized for NCCM?

A
  • Genetic NCCM
  • Sporadic NCCM
  • Benign LV hypertrabeculation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the three main categories of genetic burden for noncompaction recognized?

A
  • Patients with genetic NCCM
  • Sporadic NCCM without a genetic cause
  • Healthy individuals with benign LV hypertrabeculation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the risk for first-degree relatives if a mutation is found in NCCM?

A

They are advised to undergo DNA testing for the familial mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What percentage of NCCM patients have defects in sarcomere genes?

A

71%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the inheritance pattern of defects in sarcomere genes causing NCCM?

A

Autosomal dominant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fill in the blank: Patients with two sarcomere gene mutations may have more severe clinical features than their relatives with _______.

A

single mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Barth syndrome caused by?

A

Defects in the TAZ gene on the X chromosome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the role of mitochondrial defects in NCCM?

A

They lead to insufficient energy production required in various organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What chromosomal defect is frequently reported in children presenting with NCCM?

A

1p36 deletion syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does genetic counseling for NCCM involve?

A

Performing DNA analysis and detecting familial disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the purpose of genetic counseling in NCCM?

A

To estimate risk for relatives and convey information on the risks to index cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some mitochondrial genes linked to NCCM?

A
  • MT-ATP6
  • MT-ATP8
  • MT-CO1
  • MT-CO3
  • MT-CYB
  • MT-ND1
  • MT-ND2
  • MT-ND6.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What percentage of genetic NCCM patients may not show familial disease?

A

At least one third.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the primary role of genetic counselors in the context of NCCM?

A

To explain clinical features of the disease and the inheritance pattern, and organize informing and screening family members.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is a key component of genetic counseling related to family members?

A

Helping index cases and their relatives handle information on heredity and discussing subsequent risks and consequences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

True or False: Genetic counseling aims to make scientific information accessible both intellectually and emotionally for patients and their families.

25
What emotional responses may patients or relatives experience during genetic counseling?
Distress, anxiety, or guilt.
26
What is the purpose of obtaining family history in genetic counseling for NCCM?
To determine if cardiomyopathy is familial and identify the mode of inheritance.
27
Fill in the blank: An uninformative family history cannot completely exclude a genetic cause for _______.
NCCM
28
What percentage of NCCM patients without affected relatives are known to have a mutation?
Approximately 20%
29
What factors may contribute to the underreporting of familial cardiomyopathy?
* Affected relatives may not have been diagnosed with NCCM. * Family histories may not be informative due to small family size or little information on relatives.
30
What is the main goal of DNA testing for NCCM patients?
To identify the genetic cause for NCCM.
31
How does identifying a mutation in a family help in predictive testing?
It allows asymptomatic relatives to have a predictive DNA test identifying those at increased risk.
32
What is the significance of the genotype in NCCM patients?
It may help predict risk for ventricular systolic dysfunction and major cardiac adverse events.
33
What do NGS gene panels improve in genetic testing for NCCM?
The yield of genetic testing by allowing simultaneous analysis of multiple cardiomyopathy genes.
34
List three genes commonly included in cardiomyopathy gene panels.
* MYH7 * MYBPC3 * TTN
35
What classification system is used for interpreting DNA analysis results?
* Pathogenic variants (PV) * Likely pathogenic variants (LPV) * Variants of unknown clinical significance (VUS) * Likely benign or benign variants
36
True or False: DNA testing of pre-symptomatic family members is indicated only when there is a PV or LPV in the family.
True
37
What percentage of NCCM patients have concomitant congenital heart defects?
Around 10%
38
What is the importance of family screening in NCCM?
To determine the risk of cardiomyopathy in relatives.
39
What factors influence the risk of cardiomyopathy in relatives of NCCM patients?
* Genetic defect in the index case * Mode of inheritance * Gene-specific penetrance * Age at diagnosis of the index case
40
What is recommended for adult relatives of NCCM patients with a causative mutation?
Predictive DNA testing.
41
What psychological impact can regular hospital visits have on children undergoing screening for NCCM?
Adverse psychological effects like anxiety or depression.
42
What is a significant risk for women with NCCM during pregnancy?
Developing heart failure and/or arrhythmias.
43
What prenatal diagnostics can be discussed for women with NCCM?
* Prenatal DNA testing * Prenatal cardiac ultrasound of the fetus
44
What is the risk for women with cardiomyopathy who have symptoms before pregnancy?
Increased risk and need for specialized obstetric care ## Footnote Women with asymptomatic cardiomyopathies usually tolerate pregnancy well.
45
What is the likelihood of NCCM patients having a child with a cardiomyopathy?
Increased risk ## Footnote Prenatal diagnosis can be discussed depending on mutation presence and risk estimates.
46
Why are prenatal diagnostics for NCCM rarely requested?
The risk of severe congenital NCCM in children is small ## Footnote Symptoms of NCCM are age-related and may not be present in patients/carriers.
47
When is prenatal diagnosis for NCCM recommended?
When there is an affected child in the family ## Footnote Individual options and limitations are discussed with NCCM patients with reproductive wishes.
48
What is a significant consideration for prenatal testing in NCCM?
Familial mutation ## Footnote Prenatal DNA testing can be performed if a mutation is present in the family.
49
What are the two methods for prenatal DNA testing?
* Chorionic villus sampling (10–12 weeks) * Amniocentesis (14–20 weeks) ## Footnote Results are usually available within 2–3 weeks.
50
What should parents be informed about regarding prenatal testing interventions?
Risks for the mother and fetus, including miscarriage ## Footnote Parents may choose to terminate the pregnancy if severe conditions are detected.
51
What does prenatal cardiac sonography allow for?
Detection of fetal cardiac malformations, cardiomyopathies, and arrhythmias ## Footnote Performed in specialized tertiary prenatal centers.
52
What is a major limitation of prenatal sonography for NCCM?
Little is known about the onset and prenatal development of NCCM ## Footnote Difficulty in predicting which patients will show signs of noncompaction prenatally.
53
What psychological impact may genetic testing have on patients and their families?
Increased burden and anxiety about risk transmission ## Footnote The burden of cardiac symptoms often has a greater psychosocial impact than the genetic aspect.
54
What factor may lead to more distress in index cases undergoing genetic testing?
Having a cardiomyopathy ## Footnote Relatives usually are asymptomatic, leading to less distress.
55
What is recommended for relatives from a family with a mutation?
Cardiologic screening ## Footnote Also recommended for families without a mutation from age 10 onwards.
56
What does cardiologic screening include?
* Physical examination * 12-lead electrocardiography * Echocardiography ## Footnote Expanded cardiac work-up may be needed if abnormalities are found.
57
What should be done for mutation carriers without a phenotype?
Cardiac examination every 5 years ## Footnote They may develop a cardiomyopathy later in life due to age-related increase in penetrance.
58
What is the prevalence of cardiomyopathy identified in mutation carriers during first screening?
50–70% ## Footnote About 30% of these patients are asymptomatic.
59
When should cardiologic follow-up occur for patients diagnosed with NCCM?
Every 1–2 years or sooner if new symptoms arise ## Footnote Lifelong follow-up is required to monitor changes in symptoms and cardiac function.

Noncompaction Cardiomyopathy (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions